Yayın: Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line
| dc.contributor.author | Çinçin, Zeynep Birsu | |
| dc.contributor.author | Ünlü, Miray | |
| dc.contributor.author | Kıran, Bayram | |
| dc.contributor.author | Bireller, Elif Sinem | |
| dc.contributor.author | Baran, Yusuf | |
| dc.contributor.author | Çakmakoğlu, Bedia | |
| dc.date.accessioned | 2026-01-02T23:12:15Z | |
| dc.date.issued | 2014-08-06 | |
| dc.description.abstract | Quercetin, which is the most abundant bioflavonoid compound, is mainly present in the glycoside form of quercitrin. Although different studies indicated that quercitrin is a potent antioxidant, the action of this compound is not well understood. In this study, we investigated whether quercitrin has apoptotic and antiproliferative effects in DLD-1 colon cancer cell lines. Time and dose dependent antiproliferative and apoptotic effects of quercitrin were subsequently determined by WST-1 cell proliferation assay, lactate dehydrogenase (LDH) cytotoxicity assay, detection of nucleosome enrichment factor, changes in caspase-3 activity, loss of mitochondrial membrane potential (MMP) and also the localization of phosphatidylserine (PS) in the plasma membrane. There were significant increases in caspase-3 activity, loss of MMP, and increases in the apoptotic cell population in response to quercitrin in DLD-1 colon cancer cells in a time- and dose-dependent manner. These results revealed that quercitrin has antiproliferative and apoptotic effects on colon cancer cells. Quercitrin activity supported with in vivo analyses could be a biomarker candicate for early colorectal carcinoma. | |
| dc.description.uri | https://doi.org/10.1007/s12253-014-9825-3 | |
| dc.description.uri | https://gcris.iyte.edu.tr/bitstream/11147/5417/1/5417.pdf | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/25096395 | |
| dc.description.uri | https://dx.doi.org/10.1007/s12253-014-9825-3 | |
| dc.description.uri | http://hdl.handle.net/11147/5417 | |
| dc.identifier.doi | 10.1007/s12253-014-9825-3 | |
| dc.identifier.eissn | 1532-2807 | |
| dc.identifier.endpage | 338 | |
| dc.identifier.issn | 1219-4956 | |
| dc.identifier.openaire | doi_dedup___::5d4fe11332859a5034bd7ffc7df19834 | |
| dc.identifier.orcid | 0000-0001-8165-6164 | |
| dc.identifier.orcid | 0000-0003-3465-1808 | |
| dc.identifier.orcid | 0000-0002-1056-4673 | |
| dc.identifier.orcid | 0000-0001-7960-9131 | |
| dc.identifier.pubmed | 25096395 | |
| dc.identifier.scopus | 2-s2.0-84938214197 | |
| dc.identifier.startpage | 333 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/35856 | |
| dc.identifier.volume | 21 | |
| dc.identifier.wos | 000354265700013 | |
| dc.language.iso | eng | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Pathology & Oncology Research | |
| dc.rights | OPEN | |
| dc.subject | Membrane Potential, Mitochondrial | |
| dc.subject | Time Factors | |
| dc.subject | Dose-Response Relationship, Drug | |
| dc.subject | L-Lactate Dehydrogenase | |
| dc.subject | Caspase 3 | |
| dc.subject | Quercitrin | |
| dc.subject | Antineoplastic Agents | |
| dc.subject | Apoptosis | |
| dc.subject | Adenocarcinoma | |
| dc.subject | In Vitro Techniques | |
| dc.subject | Antioxidants | |
| dc.subject | Colon cancer | |
| dc.subject | Antineoplastic agent | |
| dc.subject | Cell Line, Tumor | |
| dc.subject | Colonic Neoplasms | |
| dc.subject | Humans | |
| dc.subject | Quercetin | |
| dc.subject | Antiproliferative | |
| dc.subject | Cell Proliferation | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
